Anders Angelsen

2.8k citations
42 papers · 2.2k · 1 hit paper · h-index 24

Impact in

Papers in

Anders Angelsen

42 papers receiving 2.1k citations

Anders Angelsen's Hit Papers

Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial 2008 · 667 citations
6670+6+12Years since publication200400600

Peers

Anders Angelsen
Comparison fields: 5 of 95
  • Pulmonary and Respiratory Medicine 1.2k
  • Cancer Research 252
  • Urology 92
  • Rheumatology 179
  • Radiation 81
Replace Peter Whelan with:
Peter Whelan United Kingdom
Luc V. Baert Belgium
Nobumichi Tanaka Japan
Matthew P. C. Liew United Kingdom
Michael D. Shelley United Kingdom
S. BRATELL Sweden
John H. L. Matthews United Kingdom
J. Erik Busby United States
Filliberto Zattoni Italy
R. R. Hall United Kingdom
Anders Angelsen relative to Peter Whelan United Kingdom Peter Whelan's profile →
Citations per field
00.5×2×3.3×
Peter Whelan · 1×
Citations per year

Countries citing papers authored by Anders Angelsen

Since Specialization
Citations

This map shows the geographic impact of Anders Angelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Angelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Angelsen more than expected).

Fields of papers citing papers by Anders Angelsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Angelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Angelsen. The network helps show where Anders Angelsen may publish in the future.

Co-authors

The 25 scholars most cited alongside Anders Angelsen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anders Angelsen Line = papers co-authored together Anders Angelsen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial
Hit paper breakdown →
2008667
2 2013160
3 2008114
4 1997104
5 200394
6 201586
7 201268
8 201667
9 201264
10 201461
11 200851
12 199750
13 201848
14 201843
15 201243
16 200743
17 201041
18 201235
19 200134
20 201430

About Anders Angelsen

Anders Angelsen is a scholar working on Pulmonary and Respiratory Medicine, Urology, Surgery, Epidemiology and Cancer Research, having authored 42 papers that have together received 2.2k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (16 papers), Prostate Cancer Treatment and Research (8 papers), Neuroendocrine Tumor Research Advances (4 papers), Metabolomics and Mass Spectrometry Studies (4 papers), Urinary Bladder and Prostate Research (2 papers), MRI in cancer diagnosis (2 papers), Cancer, Lipids, and Metabolism (2 papers) and Neuropeptides and Animal Physiology (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.2k citations), Cancer Research (252 citations), Urology (92 citations), Rheumatology (179 citations) and Radiation (81 citations). Anders Angelsen has collaborated with scholars based in Norway, Sweden and Netherlands. Frequent co-authors include Arne Solberg, Olbjørn Klepp, Anders Widmark, May‐Britt Tessem, Fredrik E. Wiklund, Morten Høyer, J.‐E. Damber, Helena Bertilsson, Trond Viset and İlker Taşdemir. Their work appears in journals such as The Prostate, European Urology, PLoS ONE, Nephrology Dialysis Transplantation and European Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact